Abstract
The moderately differentiated neuroendocrine carcinomas (MDNC) are rare tumors in the larynx. Most patients present with hoarseness and dysphagia. Commonly, these tumors have vascular or lymphatic invasion. High mitotic rate, necrosis and nuclear pleomorphism are also frequent. Once patients develop regional or distal metastasis, they usually had high mortality with poor prognosis. Unfortunately, these tumors have high tendency of regional or distal metastases, so MDNC is considered as an aggressive tumor in the larynx. Early diagnosis determines the treatment plan and outcome. Surgical removal is generally advised as the treatment of choice, and radiation therapy may have a benefit in survival. We present a 59-year-old non-smoking man with MDNC of the left supraglottic larynx, cT1N0M0, stage Ⅰ. The patient received surgical excision (pT1N0M0, stage Ⅰ) and post-operative radiation therapy (6300 cGy/35 frs). There was no evidence of recurrence for 19 months. Neither dysphasia nor hoarseness was complained. Currently, he had regular follow-up in the out-patient department.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.